Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

Important advances in oncology

Volumn , Issue , 1996, Pages 149-166

  O'Reilly, R J ^a   Lacerda, J F ^a   Lucas, K G ^a   Rosenfield, N S ^a   Small, T N ^a   Papadopoulos, E B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOTRANSPLANTATION; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DONOR; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HISTOCOMPATIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISEASE; REMISSION; REVIEW; TRANSPLANTATION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION, VIRAL; CLINICAL TRIALS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY, ADOPTIVE; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; REMISSION INDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TISSUE DONORS; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS;

EID: 0029691456     PISSN: 08835896     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (172)